Quote from wilburbear:
Stock mysteriously jumping higher.
This caused the quick pop-
Sequenom's CMM "on the brink of a growth spurt," GenomeWeb reports
Feb 18
Sequenom (SQNM) is "on the very of a recovery," according to a
spokesperson, who also noted that the company's Center for Molecular Medicine,
or CMM, is "on the brink of a growth spurt." The company recently launched its
SensiGene fetal sex-determination test and the SensiGene fetal RHD genotyping
test, which the company hopes will be adopted across the OB-GYN community. The
lab currently employs about 20 people, but "more will be needed if the new
line-up of blood tests take off."